News5 min read
Ozempic Blindness Warning: FDA Adds NAION Risk to All GLP-1s
The FDA's new Ozempic blindness warning covers every GLP-1, from Wegovy to Zepbound. What NAION is, how rare it is, and the symptoms to watch for.
What America is talking about today
Topic
The FDA's new Ozempic blindness warning covers every GLP-1, from Wegovy to Zepbound. What NAION is, how rare it is, and the symptoms to watch for.
Foundayo sleep apnea trial results: Lilly's GLP-1 pill cut breathing interruptions up to 44% in a year-long study. FDA filing timing and how it compares.